Description of Organization and Business Operations (Details)		3 Months Ended
	Nov. 17, 2020 USD ($) M $ / shares shares	Mar. 31, 2022 USD ($) $ / shares shares	Dec. 31, 2021 USD ($)	Mar. 31, 2021 USD ($)
Subsidiary, Sale of Stock [Line Items]
Payment of offering costs		$ 70,000
Percentage of aggregate fair market value of assets		80.00%
Ownership interest to be acquired on post-transaction company		50.00%
Per share value of residual assets in trust account \| $ / shares		$ 10.00
Minimum net tangible assets upon consummation of business combination		$ 5,000,001
Months To Complete Acquisition \| M	24
Percentage of shares of stock the Company is obligated to redeem without consummating a business combination		100.00%
Maturity term of U.S. government securities		185 days
Operating bank account		$ 437,951	$ 1,084,776
Working capital		1,800,000
Working Capital Loans
Subsidiary, Sale of Stock [Line Items]
Outstanding balance of related party note		0	$ 0	$ 0
Sponsor
Subsidiary, Sale of Stock [Line Items]
Proceeds from related party loan		300,000
Contribution from sponsor		$ 25,000
SAIL Securities
Subsidiary, Sale of Stock [Line Items]
Share price \| $ / shares	$ 10.00
Gross proceeds	$ 525,000,000.0
Payment of offering costs	29,800,000
Deferred underwriting commissions	$ 18,400,000
IPO
Subsidiary, Sale of Stock [Line Items]
Sale of units in initial public offering, less fair value of public warrants (in shares) \| shares	52,500,000
Share price \| $ / shares	$ 10.00
Gross proceeds	$ 525,000,000.0
Payment of offering costs	29,800,000
Deferred underwriting commissions	$ 18,400,000
Minimum percentage of shares that can be redeemed without prior consent of the Company		15.00%
Threshold trading days to redeem the shares		10 days
IPO \| SAIL Securities
Subsidiary, Sale of Stock [Line Items]
Sale of units in initial public offering, less fair value of public warrants (in shares) \| shares	52,500,000
Gross proceeds	$ 525,000,000.0
Over-allotment option
Subsidiary, Sale of Stock [Line Items]
Sale of units in initial public offering, less fair value of public warrants (in shares) \| shares		7,500,000
Deferred underwriting commissions	$ 900,000
Number of warrants to purchase the shares issued (in shares) \| shares	333,333
Over-allotment option \| SAIL Securities
Subsidiary, Sale of Stock [Line Items]
Sale of units in initial public offering, less fair value of public warrants (in shares) \| shares	2,500,000
Private Placement
Subsidiary, Sale of Stock [Line Items]
Proceeds from issuance of warrants	$ 17,500,000
Number of warrants to purchase the shares issued (in shares) \| shares	11,666,666
Price of warrants \| $ / shares	$ 1.50

Health Assurance Acquisition Corp. 10-Q